• 12683 Citations
  • 66 h-Index
1975 …2019
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Menashe Bar Eli is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Melanoma Medicine & Life Sciences
Neoplasm Metastasis Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Growth Medicine & Life Sciences
Interleukin-8 Medicine & Life Sciences
PAR-1 Receptor Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Tumors Chemical Compounds

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1975 2019

Erratum: Editor's note: Inhibition of platelet-derived growth factor–mediated proliferation of osteosarcoma cells by the novel tyrosine kinase inhibitor STI571 (Clin Cancer Res (2019) 8:3584–91))

McGary, E. C., Weber, K., Mills, L., Doucet, M., Lewis, V. O., Lev, D. C., Fidler, I. J. & Bar Eli, M., Jan 1 2019, In : Clinical Cancer Research. 25, 10, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Platelet-Derived Growth Factor
Osteosarcoma
Protein-Tyrosine Kinases
Blood Platelets
Cell Proliferation
4 Citations (Scopus)

ADAR1-mediated regulation of melanoma invasion

Nemlich, Y., Baruch, E. N., Besser, M. J., Shoshan, E., Bar Eli, M., Anafi, L., Barshack, I., Schachter, J., Ortenberg, R. & Markel, G., Dec 1 2018, In : Nature communications. 9, 1, 2154.

Research output: Contribution to journalArticle

RNA Editing
Melanoma
Transcription Factors
RNA
Tissue
10 Citations (Scopus)

A-to-I miR-378a-3p editing can prevent melanoma progression via regulation of PARVA expression

Velazquez-Torres, G., Shoshan, E., Ivan, C., Huang, L., Fuentes-Mattei, E., Paret, H., Kim, S. J., Rodriguez-Aguayo, C., Xie, V., Brooks, D., Jones, S. J. M., Robertson, A. G., Calin, G. A., Lopez-Berenstein, G., Sood, A. K. & Bar Eli, M., Dec 1 2018, In : Nature communications. 9, 1, 461.

Research output: Contribution to journalArticle

editing
MicroRNAs
progressions
Melanoma
3' Untranslated Regions
1 Citation (Scopus)

ATP11B mediates platinum resistance in ovarian cancer

Moreno-Smith, M., Halder, J. B., Meltzer, P. S., Gonda, T. A., Mangala, L. S., Rupaimoole, R., Lu, C., Nagaraja, A. S., Gharpure, K. M., Kang, Y., Rodriguez-Aguayo, C., Vivas-Mejia, P. E., Zand, B., Schmandt, R., Wang, H., Langley, R. R., Jennings, N. B., Ivan, C., Coffin, J. E., Armaiz, G. N. & 10 others, Bottsford-Miller, J., Kim, S. B., Halleck, M. S., Hendrix, M. J., Bornman, W., Bar-Eli, M., Lee, J. S., Siddik, Z. H., Lopez-Berestein, G. & Sood, A. K., Jul 2 2018, In : The Journal of clinical investigation. 128, 7, 1 p.

Research output: Contribution to journalArticle

Open Access
Platinum
Ovarian Neoplasms
11 Citations (Scopus)

Aurora kinase A is a biomarker for bladder cancer detection and contributes to its aggressive behavior

Mobley, A., Zhang, S., Bondaruk, J., Wang, Y., Majewski, T., Caraway, N. P., Huang, L., Shoshan, E., Velazquez-Torres, G., Nitti, G., Lee, S., Lee, J. G., Fuentes-Mattei, E., Willis, D., Zhang, L., Guo, C. C., Yao, H., Baggerly, K., Lotan, Y., Lerner, S. P. & 4 others, Dinney, C., McConkey, D., Bar-Eli, M. & Czerniak, B., Jan 19 2017, In : Scientific reports. 7, 40714.

Research output: Contribution to journalArticle

Aurora Kinase A
Nicotinamide N-Methyltransferase
Urinary Bladder Neoplasms
Biomarkers
Confidence Intervals